Arlington Economic Development (AED) is dedicated to the preservation and enhancement of an economically competitive and sustainable community by providing aggressive leadership and superior services to Arlington's business community, its tourism industry and its real estate development. Home to some of the most influential organizations in the world, Arlington is a world-class residential, business, and tourist location in the country's most influential region, Washington D.C.

From systems biology and in silico modeling to cheminformatics and electronic data capture, Bio-IT World shows how predictive information is the key to improving the efficiency of drug discovery, all the way through clinical trials. Critical to the goal of modeling and exploiting information is the IT and informatics infrastructure -- the hardware and software that facilitates the creation of databases, text mining and the conversion of information into hypotheses, models, and conclusions. Subscriptions are complementary for qualifying life science professionals.

The Chapman University Extended Education program provides innovative and accessible learning solutions that utilize expert knowledge and resources to empower global citizens in achieving personal and professional goals.

Early Stage East is the initial venture capital showcase for promising young companies. We serve as a gathering place for entrepreneurs and those organizations funding and servicing them in order to enable them to grow and succeed.

Early Stage East was founded in 1998 as a non-profit organization and has grown from a single-day venture capital fair to a year-round series of programs & events. Our events showcase entrepreneurs from up and down the East Coast in order for them to effectively obtain venture capital and successfully start break-away businesses.

ESE Bio-Life-Tech 2007 - December 11

The George Mason Bioscience Management Program - building on the rapidly growing Washington area bioscience community and the local presence of the National Institutes of Health (NIH) and the Food and Drug Administration - prepares bioscience professionals for leadership roles in bioscience firms and organizations. The program focuses on leadership; organizational, financial, and marketing management; and bioscience research and development management, product development, product commercialization, and entrepreneurship.

The George Mason University College of Arts and Sciences provides the intellectual foundation for undergraduate education. It has also achieved international and national recognition in selected areas of graduate education scholarship and research.

The Northern Virginia Technology Council's BioMedTech Committee focuses on promoting the convergence of the Biosciences and Information Technology which is at the leading edge of medicine and therapeutic product development. Significant progress is being made in academia and industry in combining biotechnology, information technology, and engineering to address the challenges of modern medicine. Arguably, this progress is becoming faster and faster when it comes to developing knowledge (e.g., genetic information useful for predictive medicine, high throughput screening for "druggable" targets, manufacturing technologies that create efficiency, computer modeling of diseases and therapeutic product activity). Yet, when it comes to using this knowledge to create therapeutic solutions, development is slow and costly, and we are less productive in combining the resources of multiple disciplines.

PGBase, developed by the Future Science Group, is an exciting new database for all those involved in the fields of pharmacogenomics and personalized medicine. Featuring a constantly expanding resource of Drug, Gene, Company, Diagnostic, Biomarker and Disease profiles, together with news stories, journal articles and press releases, PGBase is the only database offering comprehensive coverage of this important area of research.  Including all the latest advances in the field, as well as detailed histories of all the drugs that have already been discovered to be affected by genetic mutations, PGBase is the one-stop dynamic solution for the pharmaceutical and biotechnology industries.

Advances in pharmacogenomics and personalized medicine are facilitating the development of therapeutics tailored toward specific diseases in specific individuals. Pharmacogenomics and Personalized Medicine, published by the Future Science Group, are journals which provide readers with expert commentary and analysis on developments within these rapidly advancing fields of research.  Pharmacogenomics focuses on those aspects of most direct relevance to industrial and academic R&D scientists, and to the wider clinical community while Personalized Medicine translates recent genomic and proteomic advances into the clinical context. Each journal is subject to rigorous peer review, with three independent evaluations of each article, and industry-leading publication times.

Pharmaceutical Executive is the central forum for business and marketing executives in the global pharmaceutical industry.

The Society for Industrial Microbiology (SIM) is a professional association dedicated to the advancement of microbiological sciences, specifically as applied to industrial materials, processes, products and their associated problems. Its members constitute scientists employed in industry, government and university laboratories.